MARKET

ISPC

ISPC

iSpecimen Inc.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.25
-0.70
-10.07%
After Hours: 6.20 -0.05 -0.80% 19:58 01/14 EST
OPEN
6.50
PREV CLOSE
6.95
HIGH
6.57
LOW
5.90
VOLUME
2.04M
TURNOVER
--
52 WEEK HIGH
28.98
52 WEEK LOW
4.750
MARKET CAP
54.56M
P/E (TTM)
-4.8304
1D
5D
1M
3M
1Y
5Y
30 Stocks Moving In Friday's Mid-Day Session
Gainers ATI Physical Therapy, Inc. (NYSE: ATIP) shares gained 25.2% to $3.8050 after Jefferies upgraded the stock from Hold to Buy and raised its price target from $3.50 to $5.
Benzinga · 2d ago
ATI Physical, Cardiovascular Systems top healthcare gainers; Acutus, GeoVax among losers
Gainers: ATI Physical Therapy (NYSE:ATIP) +16%. Cardiovascular Systems (NASDAQ:CSII) +14%. Theseus Pharmaceuticals (NASDAQ:THRX) +11%. Molecular Partners (NASDAQ:MOLN) +8%.  Atara Biotherapeutics (NASDAQ:ATRA) +5%. Losers: Acutus Medical (NASDAQ:AFIB) -9%....
Seekingalpha · 2d ago
Benzinga Pro's Top 5 Stocks To Watch For Thursday, Jan. 13, 2022: NFLX, XLF, AMC, NKLA, ISPC
Today's 5 Stock Ideas: Netflix (NFLX) - The company will report quarterly results on Thursday of next week. The report will be out after market close. SPDR Select Sector Fund - Financials (XLF) - An
Benzinga · 3d ago
Why ISpecimen Shares Are Surging Higher Today
ISpecimen Inc (NASDAQ: ISPC) is trading higher Thursday after the company announced the addition of a reference lab in New York to support commercial and government customers focused on COVID-19 research.
Benzinga · 3d ago
iSpecimen jumps 12% on expansion of capabilities for COVID-19 research
iSpecimen (NASDAQ:ISPC) gains 12.2% premarket after announcing the expansion of its supplier capabilities with the addition of a reference lab in New York to support commercial and government customers focused on COVID-19 research, including
Seekingalpha · 3d ago
iSpecimen Announces Addition Of Reference Lab In New York To 'support commercial and government customers focused on COVID-19 research'
LEXINGTON, Mass., Jan. 13, 2022 /PRNewswire/ -- iSpecimen Inc. (NASDAQ:ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced
Benzinga · 3d ago
iSpecimen Expands Support of COVID-19 Research with Availability of Sequenced Specimens to Detect Variants
iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced the expansion of its supplier capabilities with the addition of a reference lab in New York to support commercial and government cus...
PR Newswire · 3d ago
See why Craig-Hallum Is Bullish On iSpecimen
Craig-Hallum initiated coverage of iSpecimen Inc (NASDAQ: ISPC) with a Buy rating and $20
Benzinga · 01/04 17:39
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ISPC. Analyze the recent business situations of iSpecimen Inc. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
100.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average ISPC stock price target is 16.00 with a high estimate of 20.00 and a low estimate of 12.00.
High20.00
Average16.00
Low12.00
Current 6.25
EPS
Actual
Estimate
-0.49-0.37-0.24-0.12
Q3 2020
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Institutional Holdings
Institutions: 9
Institutional Holdings: 916.34K
% Owned: 10.50%
Shares Outstanding: 8.73M
TypeInstitutionsShares
Increased
1
17.89K
New
7
73.16K
Decreased
0
0
Sold Out
5
296.07K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
About ISPC
iSpecimen Inc. is a technology-driven company. The Company designed iSpecimen Marketplace platform to transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. The Company’s marketplace platform ingests de-identified healthcare data provided by healthcare supply partners. The iSpecimen Marketplace supports the supply chain management and bioprocurement process for specimens and associated data. The Company’s platform helps with administrating and reporting function for researchers, suppliers, and internal personnel, including user and compliance management. The Company serves to biopharmaceutical companies, in vitro diagnostic (IVD) companies, and government/academic institutions.

Webull offers kinds of iSpecimen Inc stock information, including NASDAQ:ISPC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ISPC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ISPC stock methods without spending real money on the virtual paper trading platform.